(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.35 EUR | -1.85% | -2.74% | +16.47% |
07/05 | PHILIPS : Jefferies remains negative, but raises its target | CF |
07/05 | PHILIPS NV : Jefferies remains a Sell rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.47% | 24.18B | |
+8.07% | 219B | |
+7.87% | 184B | |
+12.75% | 138B | |
-1.37% | 62.54B | |
+4.88% | 52.22B | |
+11.59% | 51.73B | |
+2.71% | 41.4B | |
+4.90% | 37.17B | |
+23.75% | 31.76B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO